A Closer Look at the New Volatility Products On the Block

Wall Street is weighing in on the AccuShares Spot CBOE Vix Fund Up Shares (VXUP) and AccuShares Spot CBOE VIX Fund Down Shares (VXDN)

May 20, 2015 at 9:34 AM
facebook twitter linkedin


I'm cautiously optimistic that the new AccuShares Spot CBOE VIX Fund Up Shares (VXUP) and AccuShares Spot CBOE VIX Fund Down Shares (VXDN) will improve upon our current menu of tradable CBOE Volatility Index (VIX) products. Maybe it will even (gasp!) allow us to speculate on the actual VIX as opposed to some replication of VIX futures.

I asked for some opinions on Twitter and, well … not everyone shares my optimism. Here's a sampling:

That 4.5% is the daily roll of 0.15% x 30 days. It's designed to account for the mean reversion of VIX (always remember -- it's a statistic and not a stock). I don't dispute that different people studying the numbers can derive a different end result on the proper number to use and produce a number that's defensible. My guess is the disparity has to do with the fact that today's mean reversion can offset tomorrow's mean reversion and net to zero. Should that be additive, though? I'm not entirely sure, but that's why I suspect they reach different conclusions.

I do 80% agree, but there's only a 40% chance he's right on this. OK, seriously, he has a very good write-up on the product here.

That is true, as per the fact sheet. It's capped on the downside, too, though it's hard to imagine a scenario where it loses 90% of its value in a month. You do need this cap, however, given the 1:1 Creation/Redemption relationship between VXUP and VXDN. A lift of 100% or more would have a worse reaction than Independent George meeting Relationship George.

And finally, the big question. Is this just a VIX future in disguise?

The distributions accumulate for 30 days, and then at the end of that period they get paid out to the "winner." Does distribution day now become de facto expiration day of essentially a VIX future? It might. I'm going to reserve judgment on this until we see it trade for a bit. But if that's the case, we haven't accomplished much here.

Disclaimer: Mr. Warner's opinions expressed above do not necessarily represent the views of Schaeffer's Investment Research.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earnings guide for Q3 before it's too late!


  
 
Special Offers from Schaeffer's Trading Partners